- Home
- KELYB vs INBX Comparison
KELYB vs INBX Comparison
Compare KELYB & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KELYB
- INBX
- Stock Information
- Founded
- KELYB 1946
- INBX 2010
- Country
- KELYB United States
- INBX United States
- Employees
- KELYB N/A
- INBX N/A
- Industry
- KELYB Professional Services
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- KELYB Consumer Discretionary
- INBX Health Care
- Exchange
- KELYB Nasdaq
- INBX Nasdaq
- Market Cap
- KELYB 483.4M
- INBX 430.2M
- IPO Year
- KELYB N/A
- INBX 2020
- Fundamental
- Price
- KELYB $12.60
- INBX $34.81
- Analyst Decision
- KELYB
- INBX Hold
- Analyst Count
- KELYB 0
- INBX 2
- Target Price
- KELYB N/A
- INBX N/A
- AVG Volume (30 Days)
- KELYB 134.0
- INBX 162.9K
- Earning Date
- KELYB 11-06-2025
- INBX 11-13-2025
- Dividend Yield
- KELYB 2.38%
- INBX N/A
- EPS Growth
- KELYB N/A
- INBX N/A
- EPS
- KELYB N/A
- INBX N/A
- Revenue
- KELYB $4,495,900,000.00
- INBX $1,400,000.00
- Revenue This Year
- KELYB $4.55
- INBX $563.00
- Revenue Next Year
- KELYB $5.01
- INBX $230.77
- P/E Ratio
- KELYB N/A
- INBX N/A
- Revenue Growth
- KELYB 0.97
- INBX N/A
- 52 Week Low
- KELYB $11.04
- INBX $10.81
- 52 Week High
- KELYB $20.70
- INBX $37.53
- Technical
- Relative Strength Index (RSI)
- KELYB 44.85
- INBX 62.65
- Support Level
- KELYB $12.96
- INBX $31.28
- Resistance Level
- KELYB $13.47
- INBX $35.96
- Average True Range (ATR)
- KELYB 0.14
- INBX 2.21
- MACD
- KELYB -0.16
- INBX -0.22
- Stochastic Oscillator
- KELYB 0.00
- INBX 58.33
About KELYB Kelly Services Inc. Class B
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.